The Week - - City -

Bioven­tix has a niche po­si­tion in the fast-grow­ing med­i­cal equipment mar­ket, and shares are up more than 300% since join­ing Aim in 2014. CEO Peter Har­ri­son has re­warded him­self with a dis­posal worth £1.94m. He still owns 8% of the firm.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.